Citation Impact
Citing Papers
Molecular Epidemiology of EGFR and KRAS Mutations in 3,026 Lung Adenocarcinomas: Higher Susceptibility of Women to Smoking-Related KRAS -Mutant Cancers
2012
Tracking and Functional Characterization of Epithelial–Mesenchymal Transition and Mesenchymal Tumor Cells during Prostate Cancer Metastasis
2015
Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update 2014
2015 Standout
MK-2206, an Allosteric Akt Inhibitor, Enhances Antitumor Efficacy by Standard Chemotherapeutic Agents or Molecular Targeted Drugs In vitro and In vivo
2010 Standout
Loss of Fhit is frequent in stage I non-small cell lung cancer and in the lungs of chronic smokers.
1999
Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer
2009 Standout
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
Head and neck squamous cell carcinoma
2020 Standout
Shared Decision Making: A Model for Clinical Practice
2012 Standout
A systematic review of evidence on the links between patient experience and clinical safety and effectiveness
2013 Standout
Prognostic Factors in Colorectal Cancer
2000
Identifying patients with T3-T4 node-negative colon cancer at high risk of recurrence
2001
Genetics, Cytogenetics, and Epigenetics of Colorectal Cancer
2011
Microsatellite Instability in Colorectal Cancer
2010 Standout
Controversies around epithelial–mesenchymal plasticity in cancer metastasis
2019
TGFβ signalling in context
2012 Standout
Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer
2005 Standout
Autophagy as a cell death and tumor suppressor mechanism
2004 Standout
Lung Cancer
2008 Standout
Molecular Predictors of Survival after Adjuvant Chemotherapy for Colon Cancer
2001
EMT Transition States during Tumor Progression and Metastasis
2018 Standout
The role of RAS oncogene in survival of patients with lung cancer: a systematic review of the literature with meta-analysis
2004
Grading Strength of Recommendations and Quality of Evidence in Clinical Guidelines
2006 Standout
Microsatellite Instability and 8p Allelic Imbalance in Stage B2 and C Colorectal Cancers
1999
Hypermethylation of the Death-Associated Protein (DAP) Kinase Promoter and Aggressiveness in Stage I Non-Small-Cell Lung Cancer
2000
Preresectional chemotherapy in stage IIIA non-small-cell lung cancer: a 7-year assessment of a randomized controlled trial
1999
Exploiting the PI3K/AKT Pathway for Cancer Drug Discovery
2005 Standout
Predicting Response to Neoadjuvant Chemotherapy in Bladder Cancer
2019
Epithelial–mesenchymal transitions in tumour progression
2002 Standout
European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2020 Guidelines
2020 Standout
Assessment of K‐ras mutation
2009
2010 update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphoproliferative disorders and solid tumours
2010 Standout
Annual report to the nation on the status of cancer, 1975‐2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates
2009 Standout
Mitoxantrone-Induced Suicidal Erythrocyte Death
2014
Gene Silencing in Cancer in Association with Promoter Hypermethylation
2003 Standout
Going from evidence to recommendations
2008 Standout
EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphomas and solid tumours
2006
TGFβ in Cancer
2008 Standout
Microtubule-binding agents: a dynamic field of cancer therapeutics
2010 Standout
PI3K/Akt signalling pathway and cancer
2003 Standout
Tobacco Smoke Carcinogens and Lung Cancer
1999 Standout
Knowledge is not power for patients: A systematic review and thematic synthesis of patient-reported barriers and facilitators to shared decision making
2013 Standout
MicroRNA signatures in human cancers
2006 Standout
Glypican-1 identifies cancer exosomes and detects early pancreatic cancer
2015 StandoutNature
The basics of epithelial-mesenchymal transition
2009 Standout
Update on Systemic Prostate Cancer Therapies: Management of Metastatic Castration-resistant Prostate Cancer in the Era of Precision Oncology
2018
Neutrophils in cancer: neutral no more
2016 Standout
Phase II Study of Vinorelbine and Docetaxel in the Treatment of Advanced Non–Small-Cell Lung Cancer as Frontline and Second-Line Therapy
2010
Knowledge translation of research findings
2012 Standout
Glycosylation in cancer: mechanisms and clinical implications
2015 Standout
Mechanisms and pathophysiological significance of eryptosis, the suicidal erythrocyte death
2015 Standout
Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy
2012
Third-line treatment and 177Lu-PSMA radioligand therapy of metastatic castration-resistant prostate cancer: a systematic review
2017
PI3K-Akt pathway: Its functions and alterations in human cancer
2004 Standout
Perineural invasion in cancer
2009 Standout
ASCO 2006 Update of Recommendations for the Use of Tumor Markers in Gastrointestinal Cancer
2006
Laparoscopic surgery versus open surgery for colon cancer: short-term outcomes of a randomised trial
2005 Standout
Mechanisms of Acquired Androgen Independence during Arsenic-Induced Malignant Transformation of Human Prostate Epithelial Cells
2006
Endocrine-Disrupting Chemicals: An Endocrine Society Scientific Statement
2009 Standout
Prognostic factors in prostate cancer. College of American Pathologists Consensus Statement 1999.
2000
Akt/protein kinase B is constitutively active in non-small cell lung cancer cells and promotes cellular survival and resistance to chemotherapy and radiation.
2001
Gene Expression Profiles and Molecular Markers To Predict Recurrence of Dukes' B Colon Cancer
2004
Interventions for providers to promote a patient-centred approach in clinical consultations
2012 Standout
Clinical Practice Guideline for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer: 2010 Update by the Infectious Diseases Society of America
2011 Standout
Epithelial Mesenchymal Transition in Tumor Metastasis
2018 Standout
Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
2018 Standout
Decision aids for people facing health treatment or screening decisions
2017 Standout
Carboplatin/Paclitaxel or Carboplatin/Vinorelbine Followed by Accelerated Hyperfractionated Conformal Radiation Therapy: A Preliminary Report of a Phase I Dose Escalation Trial from the Carolina Conformal Therapy Consortium
2001
Tumor Microsatellite-Instability Status as a Predictor of Benefit from Fluorouracil-Based Adjuvant Chemotherapy for Colon Cancer
2003 Standout
Lutetium-177–PSMA-617 for Metastatic Castration-Resistant Prostate Cancer
2021 Standout
Morphological and immunohistochemical identification of epithelial-to-mesenchymal transition in clinical prostate cancer
2015
Metastatic Prostate Cancer
2018
Frequency and Distinctive Spectrum of KRAS Mutations in Never Smokers with Lung Adenocarcinoma
2008
Shared Decision Making — The Pinnacle of Patient-Centered Care
2012 Standout
Drug Resistance in Cancer: An Overview
2014 Standout
Chronic Inflammation and Cytokines in the Tumor Microenvironment
2014 Standout
Alterations in components of the TGF-β superfamily signaling pathways in human cancer
2005
American Society of Clinical Oncology Treatment of Unresectable Non–Small-Cell Lung Cancer Guideline: Update 2003
2003 Standout
The two faces of transforming growth factor β in carcinogenesis
2003 Standout
Irinotecan Inactivation Is Modulated by Epigenetic Silencing ofUGT1A1in Colon Cancer
2006
Works of Albert Font being referenced
Epithelial-to-Mesenchymal Transition Mediates Docetaxel Resistance and High Risk of Relapse in Prostate Cancer
2014
K-ras genotypes and prognosis in non-small-cell lung cancer
1995
Mutated K-ras gene analysis in a randomized trial of preoperative chemotherapy plus surgery versus surgery in Stage IIIA non-small cell lung cancer
1995
Weekly regimen of irinotecan/docetaxel in previously treated non-small cell lung cancer patients and correlation with uridine diphosphate glucuronosyltransferase 1A1 (UGT1A1) polymorphism
2003
Allelic loss on chromosome 18q as a prognostic marker in stage II colorectal cancer
1998
A Decision Aid to Support Informed Choices for Patients Recently Diagnosed With Prostate Cancer
2014
Increasing dose intensity of cisplatin-etoposide in advanced nonsmall cell lung carcinoma
1999
Sequential mitoxantrone/prednisone followed by docetaxel/estramustine in patients with hormone refractory metastatic prostate cancer: results of a phase II study
2005
The Role of Induction (Neoadjuvant) Chemotherapy in Stage IIIA NSCLC
1996
Prognostic value of K- ras mutations and allelic imbalance on chromosome 18q in patients with resected colorectal cancer
2001
Adjuvant therapy with bemiparin in patients with limited-stage small cell lung cancer: Results from the ABEL study
2013
BRCA1 mRNA expression and outcome to neoadjuvant cisplatin-based chemotherapy in bladder cancer
2010
Phase II non-randomized study of three different sequences of docetaxel and vinorelbine in patients with advanced non-small cell lung cancer
2002
Her-2/neu Expression in Prostate Cancer
2004
PTEN loss as a predictive biomarker for the Akt inhibitor ipatasertib combined with abiraterone acetate in patients with metastatic castration-resistant prostate cancer (mCRPC)
2016
Phase III Study Comparing a Reduced Dose of Cabazitaxel (20 mg/m2) and the Currently Approved Dose (25 mg/m2) in Postdocetaxel Patients With Metastatic Castration-Resistant Prostate Cancer—PROSELICA
2017